Where does Ark Biotech Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ark Biotech Inc. ranks #34,313 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ark Biotech Inc. hold?

Ark Biotech Inc. holds 7 US utility patents granted between 2024 and 2025, spanning 2 technology areas.

What is Ark Biotech Inc.'s Innovation Score?

Ark Biotech Inc. has an Innovation Score of 44.4 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Ark Biotech Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Ark Biotech Inc..

What does claim depth mean for Ark Biotech Inc.'s patents?

Ark Biotech Inc.'s patents average 20.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Ark Biotech Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Ark Biotech Inc.

Q: What technology areas does Ark Biotech Inc. focus on?

Ark Biotech Inc.'s top technology area is C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters) with 7 patents. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 2 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ark ranks #34,313 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 2 technology areas.

#34,313
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.4/100): 20.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R34313 · US Corporation #34,313 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #34,313/49,997
PHOTO-FINISH Aqua Satellite
CPC-NARROW C12M · 2 areas
INNOV-PAR 44.4/100
CLAIMS-DENSE 20.3 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2024–2025 · 2y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Aqua Satellite, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Ark Biotech · this assignee

44
3D Lighting… · lowest

7

What this shows Ark's Innovation Score is 44.4/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Ark's grants concentrate

Ark Biotech Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme). By volume, Ark sits between Aqua Satellite, Inc. and Artax Biopharma Inc..

Ark's three-year grant acceleration

Ark Biotech Inc. shows 5 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Aqua Satellite

7
Arcactive

7
Archipelago Group

7
Argonics

7
Arqit

7
Arrikto

7
Arrow Fastener

7
Artax Biopharma

7
Ark Biotech ◀

7

What this shows Ark holds 7 patents at rank #34,353, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ark

By rank, the assignees closest to #34,353 in granted patent volume.

Leaders in C12M (Apparatus FOR Enzymology OR Microbiology)

Other assignees with the most granted patents in Ark's primary technology class.

Ark's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2024–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.

View data table

Ark Biotech Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2024	5	71.4%
2025partial year	2	28.6%

Which technologies does Ark Biotech Inc. patent most?

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 7

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

Top 2 of 2 technology areas

Where it ranks

Overall rank by patents

#34,313

of 49,997 tracked assignees

Innovation Score

44.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Ark Biotech Inc.'s patent record in context - here's where to go next.

Ark Biotech Inc.'s lead technology class is C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme), 100% of its portfolio - see every assignee active in that class. Explore C12M
Ranked #34,313 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ark Biotech Inc. against Aqua Satellite, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.